Effectiveness of Rasona Haritaki Vati in lipid disorder {Medoroga}

A controlled clinical trial to evaluate the efficacy of Rasona Haritaki Vati in the management of Dyslipidemia with special reference to Medoroga - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102295

Enrollment

Registered

2026-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E788- Other disorders of lipoprotein metabolism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients of age group between 21 to 60 years. patient willing to enrolled in study.

Exclusion criteria

Exclusion criteria: age group less than 21 and more than 60 years of age. patient not willing for trial.

Design outcomes

Primary

Measure	Time frame
There will be significant improvement in lipid profile of patient. Timepoint: 3 month	—

Secondary

Measure	Time frame
Secondary outcome- Reduction in symptoms of Dyslipidemia and improve quality of life. Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Meera Antiwal

Faculty of Ayurveda IMS BHU

antiwalmeera@gmail.com9451586325

Outcome results